<DOC>
	<DOCNO>NCT01219452</DOCNO>
	<brief_summary>The main aim study determine whether intramuscular injection umbilical cord mesenchymal stem cell improve ventricular function child idiopathic dilate cardiomyopathy ( IDCM ) ; Secondary end-points : 1 ) To explore possible mechanism improvement ventricular function child IDCM 2 ) evaluate safety intramuscular injection umbilical cord mesenchymal stem cell .</brief_summary>
	<brief_title>Intramuscular Injection Mesenchymal Stem Cell Treatment Children With Idiopathic Dilated Cardiomyopathy</brief_title>
	<detailed_description>Children Idiopathic dilate cardiomyopathy class II III NYHA ejection fraction 20 % select phase II clinical trial , umbilical cord mesenchymal stem cell inject limb muscle follow 6 month .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Children gender establish clinical echocardiographic diagnosis dilate cardiomyopathy whose parent accept participate trail . They symptoms /or sign heart failure , despite optimized medical treatment . Ejection fraction leave ventricular less 50 % , 20 % . associate coronary artery disease . history suspicion toxic , pharmacologic deposit etiology . associate malignant pre malignant systemic disease . associate hematologic disorder . history sustain ventricular tachycardia fibrillation . history syncope previous year , active infectious disease positive test viral disease .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Dilated Cardiomyopathy</keyword>
	<keyword>Umbilical cord</keyword>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Children</keyword>
</DOC>